Abstract:Following the publication of the above article, a concerned reader drew to the Editor's attention that the Transwell cell migration and invasion assay data featured in Fig. 2C were strikingly similar to data appearing in different form in other articles written by different authors at different research institutes that had either already been published elsewhere prior to the submission of this paper to Oncology Reports , or were under consideration for publication at around the same time (some of which have been retracted). Furthermore, a number of overlapping data panels were identified comparing the migration and invasion assay data in Figs. 5C and 6C, such that data which were intended to show the results from differently performed experiments appeared to have been derived from the same original source(s). In view of the fact that certain of these data had already apparently been published previously, and given the lack of rigour on the part of the authors in assembling the data in Figs. 5 and 6, the Editor of Oncology Reports has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a satisfactory reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 37: 501‐509, 2017; DOI: 10.3892/or.2016.5242]

[Retracted] Long non‐coding RNA SNHG6 promotes tumorigenesis in melanoma cells via the microRNA‐101‐3p/RAP2B axis

Long noncoding RNA SNHG14 promotes breast cancer cell proliferation and invasion via sponging miR-193a-3p.

[Retracted] Long non‑coding RNA SNHG3 promotes the development of non‑small cell lung cancer via the miR‑1343‑3p/NFIX pathway

[Retracted] Long non‐coding RNA BCYRN1 promotes glycolysis and tumor progression by regulating the miR‐149/PKM2 axis in non‐small‐cell lung cancer

[Retracted] LncRNA GAS6 antisense RNA 1 facilitates the tumorigenesis of clear cell renal cell carcinoma by regulating the AMP‐activated protein kinase/mTOR signaling pathway

[Retracted] Long non‐coding RNA MALAT‐1 contributes to maintenance of stem cell‐like phenotypes in breast cancer cells

[Retracted] lncRNA ROR promotes the progression of renal cell carcinoma through the miR‐206/VEGF axis

[Retracted] MicroRNA‐219 is downregulated in non‐small cell lung cancer and inhibits cell growth and metastasis by targeting HMGA2

[Retracted] Long non‐coding RNA Igf2as controls hepatocellular carcinoma progression through the ERK/MAPK signaling pathway

RETRACTION: MicroRNA-155 enhances the activation of Wnt/beta-catenin signaling in colorectal carcinoma by suppressing HMG-box transcription factor 1 (Retraction of Vol 13, Pg 2221, 2016)

[Retracted] Long non‐coding RNA TMCC1‐AS1 predicts poor prognosis and accelerates epithelial‐mesenchymal transition in liver cancer

[Retracted] MicroRNA‑18b Inhibits the Growth of Malignant Melanoma Via Inhibition of HIF‑1α‑mediated Glycolysis

[Retracted] MicroRNA‐425 is downregulated in nasopharyngeal carcinoma and regulates tumor cell viability and invasion by targeting hepatoma‐derived growth factor

[Retracted] LncRNA TTN‐AS1 promotes endometrial cancer by sponging miR‐376a‐3p

[Retracted] MicroRNA‐329‐3p targets MAPK1 to suppress cell proliferation, migration and invasion in cervical cancer

[Retracted] Downregulation of long non‐coding RNA GACAT1 suppresses proliferation and induces apoptosis of NSCLC cells by sponging microRNA‐422a

[Retracted] LOC102724163 promotes breast cancer cell proliferation and invasion by stimulating MUC19 expression

[Retracted] MicroRNA‐140 represses glioma growth and metastasis by directly targeting ADAM9

[Retracted] MicroRNA‐362 is downregulated in cervical cancer and inhibits cell proliferation, migration and invasion by directly targeting SIX1

[Retracted] Circular RNA NOX4 promotes the development of colorectal cancer via the microRNA‑485‑5p/CKS1B axis

[Retracted] microRNA‐206 overexpression inhibits cellular proliferation and invasion of estrogen receptor α‐positive ovarian cancer cells